Dry eye disease is not the same for every patient. Symptoms may result from inflammation, poor tear quality, meibomian gland dysfunction, ocular surface damage, blocked oil glands, environmental factors, or a combination of underlying issues.
That is why effective dry eye care should begin with a comprehensive evaluation rather than a one-size-fits-all recommendation.
At the Dry Eye Healing Institute in West Bloomfield, Dr. Jennifer Shaba provides highly personalized care using advanced diagnostic technology, regenerative medicine, and innovative treatments for multiple stages and causes of dry eye disease.
The institute is continuing to expand its treatment capabilities with the introduction of platelet-rich plasma eye drops, also known as PRP eye drops.
Introducing PRP Eye Drops in Michigan
Dr. Shaba is proud to be the first and currently only provider in Michigan offering this specific regenerative medicine technology for the ocular surface.
PRP eye drops are created using components obtained from the patient’s own blood. The preparation contains concentrated platelets and naturally occurring growth factors that may help support the body’s healing processes.
Unlike conventional lubricating drops that primarily provide temporary moisture, PRP eye drops are intended to support the health and recovery of the ocular surface. They may be considered for certain patients experiencing moderate to severe dry eye disease, persistent ocular surface discomfort, corneal irregularities, or symptoms that have not improved sufficiently with traditional treatments.
Because PRP eye drops are produced from the patient’s own blood, they offer a personalized and biologically compatible treatment option. Every patient must first receive a complete examination to determine whether this therapy is appropriate for their condition.
Regenerative Ocular Surface Treatments From BioTissue
The Dry Eye Healing Institute also offers the full range of advanced BioTissue ocular surface products used by Dr. Shaba, including:
PROKERA
PROKERA is a biologic corneal bandage that uses cryopreserved amniotic membrane tissue to create an environment that supports corneal healing. It may be recommended for patients with significant ocular surface inflammation, corneal damage, keratitis, or moderate to severe dry eye disease.
CAM360
CAM360 is a ringless cryopreserved amniotic membrane that can be placed directly on the ocular surface. It provides another treatment option for physicians addressing dry eye disease, neurotrophic corneal conditions, and other forms of ocular surface damage.
NEOX
NEOX is a cryopreserved human tissue product used in regenerative treatment applications. Depending on the patient’s diagnosis and the extent of ocular surface disease, it may be incorporated into a customized care plan designed to protect damaged tissue and encourage healing.
Having access to multiple regenerative products allows Dr. Shaba to select an option based on the condition of the cornea, the severity of the disease, and the patient’s individual treatment goals.
Advanced Treatments for Meibomian Gland Dysfunction
Meibomian gland dysfunction, commonly called MGD, is a leading contributor to evaporative dry eye. It develops when the glands along the eyelids become obstructed or fail to release enough healthy oil into the tear film.
The Dry Eye Healing Institute offers several advanced treatments for MGD, inflammation, and gland obstruction.
Lumenis OptiLIGHT IPL
Dr. Shaba was the first physician in Michigan to offer Lumenis OptiLIGHT intense pulsed light therapy.
OptiLIGHT is the first and only IPL technology authorized by the FDA specifically for the management of signs of dry eye disease caused by meibomian gland dysfunction. The treatment applies controlled pulses of light to the area below and around the eyes to address inflammation associated with MGD.
Lumenis OptiPLUS Radiofrequency
The institute was also the first practice in Michigan to offer Lumenis OptiPLUS, an FDA-cleared dual-frequency radiofrequency technology.
OptiPLUS delivers controlled heat to the tissue surrounding the eyes. This warming effect can help target the meibomian glands and may be used alongside OptiLIGHT as part of a comprehensive treatment approach.
TearCare
TearCare uses wearable devices placed on the eyelids to deliver controlled heat while allowing the patient to blink naturally. After the oils inside the glands have been softened, Dr. Shaba can perform gland expression to help remove obstructions and improve oil flow.
Low-Level Light Therapy
Low-level light therapy, or LLLT, uses specific wavelengths of light as a noninvasive treatment for inflammation and meibomian gland dysfunction. It may be used independently or combined with other therapies based on the patient’s diagnosis.
Leadership in the Dry Eye Community
Dr. Shaba’s commitment to advancing dry eye care extends beyond her work with patients.
She is the youngest founding board member of the Dry Eye Society of the Americas, an organization created to support education, collaboration, and progress in the diagnosis and treatment of dry eye disease.
In July 2026, Dr. Shaba will speak at the Society’s conference about anti-inflammatory treatments for dry eye disease. She also serves as a key opinion leader, consultant, and member of multiple professional advisory boards.
These leadership roles allow her to contribute to important conversations about emerging treatments while remaining closely connected to advancements in ocular surface care.
A Customized Approach to Dry Eye Treatment
Dry eye can involve several interconnected problems, including tear instability, inflammation, blocked glands, insufficient tear production, eyelid conditions, and damage to the corneal surface.
For that reason, the most advanced device is not automatically the right treatment for every person. Some patients may benefit from PRP eye drops or amniotic membrane therapy, while others may need IPL, radiofrequency treatment, gland expression, prescription medication, or a combination of therapies.
At the Dry Eye Healing Institute, each treatment plan begins with a detailed assessment of the eyes, eyelids, tear film, meibomian glands, symptoms, and medical history.
The goal is to identify the factors contributing to the condition and develop a care plan that addresses more than temporary symptoms.
Schedule a Dry Eye Evaluation in West Bloomfield
Patients throughout Michigan now have access to an expanding range of regenerative and technology-based dry eye treatments at the Dry Eye Healing Institute.
To learn whether PRP eye drops, PROKERA, CAM360, NEOX, OptiLIGHT, OptiPLUS, TearCare, low-level light therapy, or another treatment may be appropriate for you, schedule a comprehensive dry eye evaluation with Dr. Jennifer Shaba.
Treatment recommendations and results vary by patient. A comprehensive eye examination is required to determine whether a particular therapy is appropriate.
